-
July 14, 2017
The current capital of the pharmaceutical company is BGN 64.3 million. Tchaikapharma High Quality Medicines Inc. announced that following the entry in the Commercial Register the capital of the company was increased by BGN 7.7 million, the announcement came through the BSE-Sofia. The current capital of the pharmaceutical company is BGN 64.3 million, divided into […]
-
June 9, 2017
The voted dividend for 2016 is 7 700 000. The amount of the capital after the increase is BGN 64 300 000. On June 8, 2017, the Annual General Meeting of Shareholders (GMS) of Tchaikapharma High Quality Medicines Inc. was held with the required quorum. A total of 56,562,089 shares were represented – all with […]
-
April 4, 2017
On the basis of art.27, par.1. it. 2 of the Ordinance No. 2 of the Financial Supervision Commission (FSC), we notify the following circumstances relating to Tchaikapharma High Quality Medicines Inc., which constitute “internal information” within the meaning of Art. 4 of the Law Against Market Abuse with Financial Instruments and Ordinance No. 2 of […]
-
December 7, 2016
The outgoing 2016 was a wonderful year of continued progress for Tchaikapharma. It was the first full year since Tchaikapharma was listed as a public company on the Bulgarian Stock Exchange (BSE) in Sofia and after share trading started on 21 May 2015. Actually and based on 3Q16 results followed by very good October and […]
-
September 9, 2016
The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companies in Bulgaria. Another pharmaceutical company – Tchaikapharma High Quality Medicines Inc. took the forefront place with a market value of […]